Severe flu management: a point of view.


Journal

Intensive care medicine
ISSN: 1432-1238
Titre abrégé: Intensive Care Med
Pays: United States
ID NLM: 7704851

Informations de publication

Date de publication:
02 2020
Historique:
received: 23 09 2019
accepted: 13 11 2019
pubmed: 9 1 2020
medline: 8 10 2020
entrez: 9 1 2020
Statut: ppublish

Résumé

Annual flu seasons are typically characterized by changes in types and subtypes of influenza, with variations in terms of severity. Despite remarkable improvements in the prevention and management of patients with suspected or laboratory-confirmed diagnosis of influenza, annual seasonal influenza continues to be associated with a high morbidity and mortality. Admission to the intensive care unit is required for patients with severe forms of seasonal influenza infection, with primary pneumonia being present in most of the cases. This review summarizes the most recent knowledge on the diagnosis and treatment strategies in critically ill patients with influenza, focused on diagnostic testing methods, antiviral therapy, use of corticosteroids, antibacterial and antifungal therapy, and supportive measures. The review focuses on diagnostic testing methods, antiviral therapy, use of corticosteroids, antibacterial and antifungal therapy, supportive measures and relevant existing evidence, in order to provide the non-expert clinician a useful overview. An enhanced understanding of current diagnostic and treatment aspects of influenza infection can contribute to improve outcomes and reduce mortality among ICU patients with influenza.

Identifiants

pubmed: 31912206
doi: 10.1007/s00134-019-05868-8
pii: 10.1007/s00134-019-05868-8
pmc: PMC7095473
doi:

Substances chimiques

Adrenal Cortex Hormones 0
Antiviral Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

153-162

Commentaires et corrections

Type : CommentIn

Références

Lancet Respir Med. 2017 May;5(5):401-411
pubmed: 28392237
N Engl J Med. 2019 May 23;380(21):1997-2008
pubmed: 31112383
Viruses. 2019 Jan 28;11(2):
pubmed: 30695992
PLoS One. 2013;8(2):e57121
pubmed: 23468921
CMAJ. 2010 Mar 9;182(4):357-63
pubmed: 20159892
Eur Respir Rev. 2014 Dec;23(134):427-38
pubmed: 25445941
J Infect Dis. 2015 Jul 15;212(2):213-22
pubmed: 25637350
Yonsei Med J. 2017 Jul;58(4):778-785
pubmed: 28540991
J Infect Dis. 2015 Dec 1;212(11):1692-700
pubmed: 25910632
Respir Care. 2017 Oct;62(10):1307-1315
pubmed: 28698265
Intensive Care Med. 2017 Jan;43(1):48-58
pubmed: 27709265
J Infect Dis. 2019 Aug 9;220(6):969-979
pubmed: 31070757
Nat Commun. 2019 Jul 31;10(1):3422
pubmed: 31366921
Intensive Care Med. 2018 Sep;44(9):1470-1482
pubmed: 30074052
Vaccine. 2018 Apr 12;36(16):2166-2175
pubmed: 29548608
Lancet Infect Dis. 2018 Jan;18(1):95-107
pubmed: 29037960
Ther Drug Monit. 2012 Apr;34(2):171-5
pubmed: 22354159
Intensive Care Med. 2011 May;37(5):796-800
pubmed: 21369807
J Infect Dis. 2019 Mar 15;219(7):1151-1161
pubmed: 30339221
Expert Rev Clin Pharmacol. 2017 Jan;10(1):81-95
pubmed: 27797595
Lancet Infect Dis. 2016 Jul;16(7):819-827
pubmed: 26947523
Ann Intern Med. 2017 Sep 19;167(6):394-409
pubmed: 28869986
Intensive Care Med. 2017 Apr;43(4):568-569
pubmed: 27515160
Crit Care. 2016 Oct 23;20(1):337
pubmed: 27770828
Intensive Care Med. 2015 Apr;41(4):633-41
pubmed: 25693449
PLoS One. 2016 Jan 20;11(1):e0146620
pubmed: 26788921
Intensive Care Med. 2016 Dec;42(12):1958-1969
pubmed: 27695884
Eur Respir J. 2016 Dec;48(6):1764-1778
pubmed: 27811073
J Clin Microbiol. 2016 Aug;54(8):2096-103
pubmed: 27225406
Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67
pubmed: 31573350
J Clin Virol. 2011 Apr;50(4):320-4
pubmed: 21330192
Crit Care. 2013 Feb 13;17(1):R30
pubmed: 23406535
Am J Emerg Med. 2013 Jan;31(1):137-44
pubmed: 22944552
Eur Respir J. 2015 Jun;45(6):1642-52
pubmed: 25573405
Clin Infect Dis. 2019 Jun 18;69(1):24-33
pubmed: 30285232
Crit Care. 2019 Mar 27;23(1):99
pubmed: 30917856
Trials. 2015 May 24;16:226
pubmed: 26003545
Am J Respir Crit Care Med. 2012 Nov 1;186(9):929-30
pubmed: 23118087
Intensive Care Med. 2018 Jan;44(1):22-37
pubmed: 29218379
Int J Antimicrob Agents. 2016 Aug;48(2):215-9
pubmed: 27319273
Chest. 2010 May;137(5):1203-16
pubmed: 20442122
Curr Opin Crit Care. 2016 Feb;22(1):53-9
pubmed: 26627539
J Infect Dis. 2019 Mar 15;219(7):1026-1034
pubmed: 30428049
Clin Infect Dis. 2010 Mar 15;50(6):850-9
pubmed: 20136415
Lancet Respir Med. 2018 Oct;6(10):782-792
pubmed: 30076119
Chest. 2016 Oct;150(4):819-828
pubmed: 27107491
Clin Infect Dis. 2019 Mar 5;68(6):e1-e47
pubmed: 30566567
Fed Regist. ;82(8):3609-19
pubmed: 28102980
Clin Infect Dis. 2019 Mar 5;68(6):895-902
pubmed: 30834445
Crit Care. 2019 Jun 12;23(1):214
pubmed: 31189475
Ann Card Anaesth. 2017 Jan-Mar;20(1):14-21
pubmed: 28074789
Intensive Care Med. 2019 Feb;45(2):159-171
pubmed: 30706119
Lancet Respir Med. 2014 May;2(5):395-404
pubmed: 24815805
J Clin Microbiol. 2018 Jun 25;56(7):
pubmed: 29695519
PLoS One. 2017 Jun 7;12(6):e0178926
pubmed: 28591230
J Infect Dis. 2020 Jan 14;221(3):346-355
pubmed: 31309975
Expert Rev Mol Diagn. 2017 Oct;17(10):917-931
pubmed: 28841814
Intensive Care Med. 2017 Sep;43(9):1395-1397
pubmed: 28421245
Antiviral Res. 2018 Feb;150:202-216
pubmed: 29325970
Lancet Infect Dis. 2017 Dec;17(12):1255-1265
pubmed: 28958678
N Engl J Med. 2018 Sep 6;379(10):913-923
pubmed: 30184455
Inflamm Res. 2019 Jan;68(1):39-46
pubmed: 30288556
Nat Immunol. 2018 Jun;19(6):625-635
pubmed: 29777224
Sci Rep. 2017 Jul 26;7(1):6548
pubmed: 28747714
Crit Care. 2019 May 2;23(1):152
pubmed: 31046842
Curr Opin Infect Dis. 2018 Dec;31(6):520-526
pubmed: 30299356
Cochrane Database Syst Rev. 2017 Oct 12;10:CD007498
pubmed: 29025194
J Clin Microbiol. 2014 Feb;52(2):497-501
pubmed: 24478479
Open Forum Infect Dis. 2017 Jun 19;4(3):ofx129
pubmed: 28761899
Antivir Ther. 2011;16(2):237-47
pubmed: 21447873

Auteurs

Antoni Torres (A)

Service of Pneumology, Hospital Clinic of Barcelona, University of Barcelona, Institut d'Investigació August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomédica en Red, Enfermedades Respiratorias (CIBERES), C/Villarroel 170, 08036, Barcelona, Spain. atorres@clinic.cat.

Ignacio-Martin- Loeches (IM)

Service of Pneumology, Hospital Clinic of Barcelona, University of Barcelona, Institut d'Investigació August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomédica en Red, Enfermedades Respiratorias (CIBERES), C/Villarroel 170, 08036, Barcelona, Spain.
Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization (MICRO), St. James's Hospital, Dublin, Ireland.

Wendy Sligl (W)

Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Canada.
Department of Critical Care Medicine, University of Alberta, Edmonton, Canada.

Nelson Lee (N)

Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH